These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Frequency and differential diagnosis of depressive syndromes in schizophrenia. Martin RL; Cloninger CR; Guze SB; Clayton PJ J Clin Psychiatry; 1985 Nov; 46(11 Pt 2):9-13. PubMed ID: 2865255 [TBL] [Abstract][Full Text] [Related]
4. Overlap between emotional blunting, depression, and extrapyramidal symptoms in schizophrenia. Müller M Schizophr Res; 2002 Oct; 57(2-3):307. PubMed ID: 12223263 [No Abstract] [Full Text] [Related]
5. A discriminant validity study of negative symptoms with a special focus on depression and antipsychotic medication. Lewine RR Am J Psychiatry; 1990 Nov; 147(11):1463-6. PubMed ID: 1977328 [TBL] [Abstract][Full Text] [Related]
6. A "folie à deux" dystonic reaction. Cavenar JO; Harris MA Am J Psychiatry; 1980 Jan; 137(1):99-100. PubMed ID: 7352570 [No Abstract] [Full Text] [Related]
8. Commentary on the Modified Rogers Scale and the 'conflict of paradigms' hypothesis. Liddle PF Br J Psychiatry; 1991 Mar; 158():337-9. PubMed ID: 2036531 [No Abstract] [Full Text] [Related]
9. The basal ganglia and cognitive pattern generators. Graybiel AM Schizophr Bull; 1997; 23(3):459-69. PubMed ID: 9327509 [TBL] [Abstract][Full Text] [Related]
10. [Three-dimensional ultrasonic movement analysis of gait and hand-movements in schizophrenic patients]. Putzhammer A; Perfahl M; Pfeiff L; Müller JL Psychiatr Prax; 2005 Apr; 32 Suppl 1():S38-42. PubMed ID: 15818519 [TBL] [Abstract][Full Text] [Related]
11. Assessing negative symptoms and extrapyramidal symptoms in schizophrenia: workshop report. Kane JM; Dauphinais D; Barnes TR; Adler LA; Rifkin A Psychopharmacol Bull; 1993; 29(1):45-9. PubMed ID: 8104351 [No Abstract] [Full Text] [Related]
12. Prevalence of obsessive-compulsive disorder in schizophrenia and significance of motor symptoms. Krüger S; Bräunig P; Höffler J; Shugar G; Börner I; Langkrär J J Neuropsychiatry Clin Neurosci; 2000; 12(1):16-24. PubMed ID: 10678507 [TBL] [Abstract][Full Text] [Related]
13. Empirical validation of primary negative symptoms: independence from effects of medication and psychosis. Kelley ME; van Kammen DP; Allen DN Am J Psychiatry; 1999 Mar; 156(3):406-11. PubMed ID: 10080556 [TBL] [Abstract][Full Text] [Related]
14. Basal ganglia T2 relaxation times in schizophrenia: a quantitative magnetic resonance imaging study in relation to tardive dyskinesia. Buckley P; O'Callaghan E; Mulvany F; Larkin C; Stack JP; Redmond O; Ennis JT; Thompson P; Waddington JL Psychiatry Res; 1995 Aug; 61(2):95-102. PubMed ID: 7480392 [TBL] [Abstract][Full Text] [Related]
15. Motor, volitional and behavioural disorders in schizophrenia. 2: The 'conflict of paradigms' hypothesis. McKenna PJ; Lund CE; Mortimer AM; Biggins CA Br J Psychiatry; 1991 Mar; 158():328-36. PubMed ID: 2036530 [TBL] [Abstract][Full Text] [Related]
16. Extrapyramidal syndromes and new antipsychotic drugs: findings in patients and non-human primate models. Casey DE Br J Psychiatry Suppl; 1996 May; (29):32-9. PubMed ID: 8733821 [No Abstract] [Full Text] [Related]
17. Affective flattening and the criteria for schizophrenia. Andreasen NC Am J Psychiatry; 1979 Jul; 136(7):944-7. PubMed ID: 453357 [TBL] [Abstract][Full Text] [Related]
18. Clinical heterogeneity of schizophrenia. Dollfus S; Brazo P Psychopathology; 1997; 30(5):275-81. PubMed ID: 9353856 [TBL] [Abstract][Full Text] [Related]
19. Clozapine, negative symptoms, and extrapyramidal side effects. Kane JM; Safferman AZ; Pollack S; Johns C; Szymanski S; Kronig M; Lieberman JA J Clin Psychiatry; 1994 Sep; 55 Suppl B():74-7. PubMed ID: 7961579 [TBL] [Abstract][Full Text] [Related]
20. A pilot study of a structured interview addressing sexual function in men with schizophrenia. Burke MA; McEvoy JP; Ritchie JC Biol Psychiatry; 1994 Jan; 35(1):32-5. PubMed ID: 8167201 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]